Загрузка видео...

Не удалось загрузить видео

На главную

Fenbendazole & Cancer Remission: The Peer-Reviewed Cases Challenging Modern Oncology A peer-reviewed medical publication has delivered a bombshell that the mainstream oncology world cannot ignore. It documents three cases of patients with advanced, metastatic cancer who achieved remarkable remissions after a radical course of action: self-medicating with veterinary-grade medication....

newstart_2024's profile picture

Camus

460,881 subscribers

50,224 просмотров • 9 месяцев назад •via X (Twitter)

LIVE

Anya Rossi• Live Now

Private livecam show

Комментарии: 0

Нет доступных комментариев

Здесь появятся комментарии из оригинального поста

Похожие видео

Oncologist Dr. William Makis describes getting attacked by the president of City of Hope cancer centers for publishing success stories using antiparasitics to treat turbo cancers: "These antiparasitics are being heavily attacked and are being suppressed every time I mention ivermectin, mebendazole, [and] fenbendazole. And I have hundreds of success stories...." This clip of Dr. Makis, a radiologist, oncologist, and cancer researcher, is taken from a panel discussion posted to the World Council for Health Rumble channel on November 24, 2025. ---------------Partial transcription of clip---------------- "So these antiparasitics are being heavily attacked, and are being suppressed every time I mention ivermectin, mebendazole, fenbendazole, and I have hundreds of success stories. I get attacked. I get attacked by mainstream doctors and mainstream oncologists. "And just going back to what Kevin McKernan said about this phenomenon of trying to retract papers, get good papers retracted, I've had this happen to me very recently. We published recently a paper on fenbendazole. Three cases of stage four cancer patients who had failed three or four or five lines of chemotherapy, and mainstream oncology regimens. These cancer patients were dying. They took fenbendazole and they became cancer free. And we followed them up, up to three years. They stayed cancer three for up to three years. So we had three cases. We published this paper a few months ago. This was only the second paper published on the antiparasitic fenbendazole in the past five years with human cases. The first one was published by Stanford University in 2021. And so they had published three cases in 2021. We published three cases in 2025. Within a month or two of the publication of our paper. Now it passed peer review and it was published. We were attacked by the editor of the paper, who's actually the president of the City of Hope cancer centers in the United States, in Atlanta, Chicago, and Phoenix. "This was Dr. Maurice [Maurie] Markman, President of City of Hope, so a big time oncologist, with a lot of, you know, big pharma funding behind him. He said he's going to pull the paper. And they didn't have a good reason to pull the paper. In fact, the reason that they were putting was that I was giving, you know, medical advice to other cancer patients with fenbendazole. And so that was some kind of a conflict of interest. And because, you know, that wasn't declared in the way they liked, that they were going to pull the paper. "And so, you know, this is an attack. We're going to see these attacks not just on Kevin McKernan and David Speicher's work in trying to make the link between Covid vaccines and these turbo cancers. But even those of us who are going to try to treat these patients, and help these patients and try to get that work published with antiparasitics and these turbo cancers, we're being attacked, and our papers are being attacked for retraction as well." #Fenbendazole #Ivermectin #Cancercure
2:33

Oncologist Dr. William Makis describes getting attacked by the president of City of Hope cancer centers for publishing success stories using antiparasitics to treat turbo cancers: "These antiparasitics are being heavily attacked and are being suppressed every time I mention ivermectin, mebendazole, [and] fenbendazole. And I have hundreds of success stories...." This clip of Dr. Makis, a radiologist, oncologist, and cancer researcher, is taken from a panel discussion posted to the World Council for Health Rumble channel on November 24, 2025. ---------------Partial transcription of clip---------------- "So these antiparasitics are being heavily attacked, and are being suppressed every time I mention ivermectin, mebendazole, fenbendazole, and I have hundreds of success stories. I get attacked. I get attacked by mainstream doctors and mainstream oncologists. "And just going back to what Kevin McKernan said about this phenomenon of trying to retract papers, get good papers retracted, I've had this happen to me very recently. We published recently a paper on fenbendazole. Three cases of stage four cancer patients who had failed three or four or five lines of chemotherapy, and mainstream oncology regimens. These cancer patients were dying. They took fenbendazole and they became cancer free. And we followed them up, up to three years. They stayed cancer three for up to three years. So we had three cases. We published this paper a few months ago. This was only the second paper published on the antiparasitic fenbendazole in the past five years with human cases. The first one was published by Stanford University in 2021. And so they had published three cases in 2021. We published three cases in 2025. Within a month or two of the publication of our paper. Now it passed peer review and it was published. We were attacked by the editor of the paper, who's actually the president of the City of Hope cancer centers in the United States, in Atlanta, Chicago, and Phoenix. "This was Dr. Maurice [Maurie] Markman, President of City of Hope, so a big time oncologist, with a lot of, you know, big pharma funding behind him. He said he's going to pull the paper. And they didn't have a good reason to pull the paper. In fact, the reason that they were putting was that I was giving, you know, medical advice to other cancer patients with fenbendazole. And so that was some kind of a conflict of interest. And because, you know, that wasn't declared in the way they liked, that they were going to pull the paper. "And so, you know, this is an attack. We're going to see these attacks not just on Kevin McKernan and David Speicher's work in trying to make the link between Covid vaccines and these turbo cancers. But even those of us who are going to try to treat these patients, and help these patients and try to get that work published with antiparasitics and these turbo cancers, we're being attacked, and our papers are being attacked for retraction as well." #Fenbendazole #Ivermectin #Cancercure

Joe Tippens

32,159 просмотров • 1 месяц назад

10 Shocking Stories the Media Buried This Week #10 - Cancer remission achieved with low-cost drug, a jaw-dropping case series reveals. 3 patients experienced complete remission after regularly taking fenbendazole. But the cancer industry seems to hate it because it only costs about $11 per week. Fenbendazole (FBZ) is a medicine originally designed to treat worms and parasites in animals. Its sister drugs, Mebendazole and Albendazole, have had remarkable success treating similar ailments in humans with few side effects. The case series highlights the remarkable stories of three cancer patients who achieved miraculous recoveries with fenbendazole after exhausting all conventional therapies. After analyzing these cases, the abstract concluded, “FBZ appears to be a potentially safe and effective antineoplastic agent that can be repurposed for human use in treating genitourinary malignancies.” Adding to the growing evidence in support of fendendazole’s use case against cancer, an Oklahoma man credited his miraculous cancer recovery to the pet med after overcoming terminal small cell lung cancer, defying a less than 1% survival rate and leaving doctors baffled. This story is truly remarkable. Watch. (See 9 More Revealing Stories Below)
15:05

10 Shocking Stories the Media Buried This Week #10 - Cancer remission achieved with low-cost drug, a jaw-dropping case series reveals. 3 patients experienced complete remission after regularly taking fenbendazole. But the cancer industry seems to hate it because it only costs about $11 per week. Fenbendazole (FBZ) is a medicine originally designed to treat worms and parasites in animals. Its sister drugs, Mebendazole and Albendazole, have had remarkable success treating similar ailments in humans with few side effects. The case series highlights the remarkable stories of three cancer patients who achieved miraculous recoveries with fenbendazole after exhausting all conventional therapies. After analyzing these cases, the abstract concluded, “FBZ appears to be a potentially safe and effective antineoplastic agent that can be repurposed for human use in treating genitourinary malignancies.” Adding to the growing evidence in support of fendendazole’s use case against cancer, an Oklahoma man credited his miraculous cancer recovery to the pet med after overcoming terminal small cell lung cancer, defying a less than 1% survival rate and leaving doctors baffled. This story is truly remarkable. Watch. (See 9 More Revealing Stories Below)

Vigilant Fox 🦊

1,166,512 просмотров • 1 год назад

Can Fenbendazole Cure Cancer? According to a case series published in an oncology journal, the answer could be a resounding yes. The case report highlights three cancer patients who were in pretty bad shape. But after taking fenbendazole, they all experienced a complete remission. What Is Fenbendazole, and How Does it Work? Fenbendazole (FBZ) is a medicine originally designed to treat worms and parasites in animals. Its sister drugs, Mebendazole and Albendazole, have had remarkable success treating similar ailments in humans with few side effects. Recently, anecdotal reports have praised fenbendazole as a potentially miraculous anti-cancer drug. It works by destabilizing microtubules, the structures that help cancer cells divide and grow. By disrupting this process, fenbendazole effectively halts cancer cell division and slows or stops tumor growth. Miraculous Recoveries After Taking Fenbendazole Case series #1 features a 63-year-old man with advanced kidney cancer (clear cell renal carcinoma) who experienced tumor recurrence and severe side effects from multiple cancer therapies, including surgery and two different medications. With no effective options left, he turned to fenbendazole (FBZ), taking 1 gram three times a week at a friend’s suggestion. Over the next 10 months, his tumors—including those in his pancreas and spine—showed near-complete resolution on imaging. Remarkably, he experienced no side effects from FBZ, and follow-up scans have shown no signs of recurrence. Case series #2 follows a 72-year-old man with metastatic urethral cancer that had spread to his lungs, lymph nodes, and brain. Despite undergoing multiple rounds of chemotherapy and radiation, one lymph node continued to grow, resisting all treatments. Seeking alternatives, he decided to try fenbendazole (FBZ), taking 1 gram three times a week, along with vitamin E, curcumin, and CBD oil, while postponing further conventional therapies. Over the next nine months, imaging revealed a dramatic response, with the lymph node shrinking significantly until it completely resolved. Remarkably, he reported no side effects during this period. Case series #3 focuses on a 63-year-old woman diagnosed with a large, invasive bladder tumor. Facing a challenging prognosis, she underwent chemotherapy while also taking fenbendazole (FBZ) at 1 gram three times a week. After completing six cycles of treatment, follow-up scans showed a complete resolution of the tumor, with only minimal thickening remaining in the bladder wall. Confident in her recovery, she chose to decline further surgery and remains disease-free under regular surveillance. The abstract concluded, “FBZ appears to be a potentially safe and effective antineoplastic agent that can be repurposed for human use in treating genitourinary malignancies.” Reflecting on these remarkable case reports, Dr. John Campbell (John Campbell) urged drug regulators to “start looking at this as a matter of some urgency because people are dying from cancer now.” “So if something is safe and effective, surely it can be accredited for human use by our national authorizing agencies pretty quickly if they want to,” Dr. Campbell added with a hint of sarcasm. Of course, the key words here are “if they want to.” “Three patients, basically… cured of their cancers. Read the paper for yourself. That’s what they seem to be saying to me.”
3:34

Can Fenbendazole Cure Cancer? According to a case series published in an oncology journal, the answer could be a resounding yes. The case report highlights three cancer patients who were in pretty bad shape. But after taking fenbendazole, they all experienced a complete remission. What Is Fenbendazole, and How Does it Work? Fenbendazole (FBZ) is a medicine originally designed to treat worms and parasites in animals. Its sister drugs, Mebendazole and Albendazole, have had remarkable success treating similar ailments in humans with few side effects. Recently, anecdotal reports have praised fenbendazole as a potentially miraculous anti-cancer drug. It works by destabilizing microtubules, the structures that help cancer cells divide and grow. By disrupting this process, fenbendazole effectively halts cancer cell division and slows or stops tumor growth. Miraculous Recoveries After Taking Fenbendazole Case series #1 features a 63-year-old man with advanced kidney cancer (clear cell renal carcinoma) who experienced tumor recurrence and severe side effects from multiple cancer therapies, including surgery and two different medications. With no effective options left, he turned to fenbendazole (FBZ), taking 1 gram three times a week at a friend’s suggestion. Over the next 10 months, his tumors—including those in his pancreas and spine—showed near-complete resolution on imaging. Remarkably, he experienced no side effects from FBZ, and follow-up scans have shown no signs of recurrence. Case series #2 follows a 72-year-old man with metastatic urethral cancer that had spread to his lungs, lymph nodes, and brain. Despite undergoing multiple rounds of chemotherapy and radiation, one lymph node continued to grow, resisting all treatments. Seeking alternatives, he decided to try fenbendazole (FBZ), taking 1 gram three times a week, along with vitamin E, curcumin, and CBD oil, while postponing further conventional therapies. Over the next nine months, imaging revealed a dramatic response, with the lymph node shrinking significantly until it completely resolved. Remarkably, he reported no side effects during this period. Case series #3 focuses on a 63-year-old woman diagnosed with a large, invasive bladder tumor. Facing a challenging prognosis, she underwent chemotherapy while also taking fenbendazole (FBZ) at 1 gram three times a week. After completing six cycles of treatment, follow-up scans showed a complete resolution of the tumor, with only minimal thickening remaining in the bladder wall. Confident in her recovery, she chose to decline further surgery and remains disease-free under regular surveillance. The abstract concluded, “FBZ appears to be a potentially safe and effective antineoplastic agent that can be repurposed for human use in treating genitourinary malignancies.” Reflecting on these remarkable case reports, Dr. John Campbell (John Campbell) urged drug regulators to “start looking at this as a matter of some urgency because people are dying from cancer now.” “So if something is safe and effective, surely it can be accredited for human use by our national authorizing agencies pretty quickly if they want to,” Dr. Campbell added with a hint of sarcasm. Of course, the key words here are “if they want to.” “Three patients, basically… cured of their cancers. Read the paper for yourself. That’s what they seem to be saying to me.”

The Vigilant Fox 🦊

1,478,253 просмотров • 1 год назад

Can Fenbendazole Cure Cancer? According to a case series published in an oncology journal, the answer could be a resounding yes. The case report highlights three cancer patients who were in pretty bad shape. But after taking fenbendazole, they all experienced a complete remission. What Is Fenbendazole, and How Does it Work? Fenbendazole (FBZ) is a medicine originally designed to treat worms and parasites in animals. Its sister drugs, Mebendazole and Albendazole, have had remarkable success treating similar ailments in humans with few side effects. Recently, anecdotal reports have praised fenbendazole as a potentially miraculous anti-cancer drug. It works by destabilizing microtubules, the structures that help cancer cells divide and grow. By disrupting this process, fenbendazole effectively halts cancer cell division and slows or stops tumor growth. Miraculous Recoveries After Taking Fenbendazole Case series #1 features a 63-year-old man with advanced kidney cancer (clear cell renal carcinoma) who experienced tumor recurrence and severe side effects from multiple cancer therapies, including surgery and two different medications. With no effective options left, he turned to fenbendazole (FBZ), taking 1 gram three times a week at a friend’s suggestion. Over the next 10 months, his tumors—including those in his pancreas and spine—showed near-complete resolution on imaging. Remarkably, he experienced no side effects from FBZ, and follow-up scans have shown no signs of recurrence. Case series #2 follows a 72-year-old man with metastatic urethral cancer that had spread to his lungs, lymph nodes, and brain. Despite undergoing multiple rounds of chemotherapy and radiation, one lymph node continued to grow, resisting all treatments. Seeking alternatives, he decided to try fenbendazole (FBZ), taking 1 gram three times a week, along with vitamin E, curcumin, and CBD oil, while postponing further conventional therapies. Over the next nine months, imaging revealed a dramatic response, with the lymph node shrinking significantly until it completely resolved. Remarkably, he reported no side effects during this period. Case series #3 focuses on a 63-year-old woman diagnosed with a large, invasive bladder tumor. Facing a challenging prognosis, she underwent chemotherapy while also taking fenbendazole (FBZ) at 1 gram three times a week. After completing six cycles of treatment, follow-up scans showed a complete resolution of the tumor, with only minimal thickening remaining in the bladder wall. Confident in her recovery, she chose to decline further surgery and remains disease-free under regular surveillance. The abstract concluded, “FBZ appears to be a potentially safe and effective antineoplastic agent that can be repurposed for human use in treating genitourinary malignancies.” Reflecting on these remarkable case reports, Dr. John Campbell (John Campbell) urged drug regulators to “start looking at this as a matter of some urgency because people are dying from cancer now.” “So if something is safe and effective, surely it can be accredited for human use by our national authorizing agencies pretty quickly if they want to,” Dr. Campbell added with a hint of sarcasm. Of course, the key words here are “if they want to.” “Three patients, basically… cured of their cancers. Read the paper for yourself. That’s what they seem to be saying to me.”
3:35

Can Fenbendazole Cure Cancer? According to a case series published in an oncology journal, the answer could be a resounding yes. The case report highlights three cancer patients who were in pretty bad shape. But after taking fenbendazole, they all experienced a complete remission. What Is Fenbendazole, and How Does it Work? Fenbendazole (FBZ) is a medicine originally designed to treat worms and parasites in animals. Its sister drugs, Mebendazole and Albendazole, have had remarkable success treating similar ailments in humans with few side effects. Recently, anecdotal reports have praised fenbendazole as a potentially miraculous anti-cancer drug. It works by destabilizing microtubules, the structures that help cancer cells divide and grow. By disrupting this process, fenbendazole effectively halts cancer cell division and slows or stops tumor growth. Miraculous Recoveries After Taking Fenbendazole Case series #1 features a 63-year-old man with advanced kidney cancer (clear cell renal carcinoma) who experienced tumor recurrence and severe side effects from multiple cancer therapies, including surgery and two different medications. With no effective options left, he turned to fenbendazole (FBZ), taking 1 gram three times a week at a friend’s suggestion. Over the next 10 months, his tumors—including those in his pancreas and spine—showed near-complete resolution on imaging. Remarkably, he experienced no side effects from FBZ, and follow-up scans have shown no signs of recurrence. Case series #2 follows a 72-year-old man with metastatic urethral cancer that had spread to his lungs, lymph nodes, and brain. Despite undergoing multiple rounds of chemotherapy and radiation, one lymph node continued to grow, resisting all treatments. Seeking alternatives, he decided to try fenbendazole (FBZ), taking 1 gram three times a week, along with vitamin E, curcumin, and CBD oil, while postponing further conventional therapies. Over the next nine months, imaging revealed a dramatic response, with the lymph node shrinking significantly until it completely resolved. Remarkably, he reported no side effects during this period. Case series #3 focuses on a 63-year-old woman diagnosed with a large, invasive bladder tumor. Facing a challenging prognosis, she underwent chemotherapy while also taking fenbendazole (FBZ) at 1 gram three times a week. After completing six cycles of treatment, follow-up scans showed a complete resolution of the tumor, with only minimal thickening remaining in the bladder wall. Confident in her recovery, she chose to decline further surgery and remains disease-free under regular surveillance. The abstract concluded, “FBZ appears to be a potentially safe and effective antineoplastic agent that can be repurposed for human use in treating genitourinary malignancies.” Reflecting on these remarkable case reports, Dr. John Campbell (John Campbell) urged drug regulators to “start looking at this as a matter of some urgency because people are dying from cancer now.” “So if something is safe and effective, surely it can be accredited for human use by our national authorizing agencies pretty quickly if they want to,” Dr. Campbell added with a hint of sarcasm. Of course, the key words here are “if they want to.” “Three patients, basically… cured of their cancers. Read the paper for yourself. That’s what they seem to be saying to me.”

The Vigilant Fox 🦊

405,353 просмотров • 1 год назад

🚨 THIS WAS NEVER SUPPOSED TO BE A CANCER DRUG Fenbendazole was developed to treat parasites. Not cancer. Which is why researchers were surprised enough to publish a case series describing three patients whose cancers reportedly went into remission after using it. Cancer survives by dividing over and over again. Fenbendazole appears to interfere with microtubules, structures cells need to complete that process. The paper doesn't claim fenbendazole is a cure. But it does explain why this decades-old antiparasitic keeps showing up in cancer discussions around the world. And once people start reading the studies for themselves, the next question usually isn't "Does this exist?" It's "Where can I get it?" That's why thousands turn to PharmacyinUSA for fenbendazole, ivermectin, and other repurposed medicines.
3:35

🚨 THIS WAS NEVER SUPPOSED TO BE A CANCER DRUG Fenbendazole was developed to treat parasites. Not cancer. Which is why researchers were surprised enough to publish a case series describing three patients whose cancers reportedly went into remission after using it. Cancer survives by dividing over and over again. Fenbendazole appears to interfere with microtubules, structures cells need to complete that process. The paper doesn't claim fenbendazole is a cure. But it does explain why this decades-old antiparasitic keeps showing up in cancer discussions around the world. And once people start reading the studies for themselves, the next question usually isn't "Does this exist?" It's "Where can I get it?" That's why thousands turn to PharmacyinUSA for fenbendazole, ivermectin, and other repurposed medicines.

PharmacyinUSA

14,784 просмотров • 2 месяцев назад

Ivermectin & Fenbendazole Cancer Secrets Revealed w/ Dr. William Makis Remarkable success stories are pouring in from people using Ivermectin and Fenbendazole to combat cancer. Mel Gibson dropped a bombshell on Joe Rogan’s podcast, revealing that three of his friends had “stage four cancer,” and now “all three of them don’t have cancer right now at all.” “And they had some serious stuff going on,” Gibson emphasized. Dr. William Makis, who treated one of Gibson’s friends, has been rigorously researching the anti-cancer potential of Ivermectin and Fenbendazole over the past two years. During that time, he discovered, “There are over 100 papers on the success of Ivermectin and cancer.” “Ivermectin can actually kill cancer stem cells,” Dr. Makis explained, noting that it targets the cells “that chemo can’t kill.” He added, “It can also reverse resistance that cancer cells develop to certain types of chemotherapy.” The benefits extend further. “It [Ivermectin] makes cancer cells susceptible to radiation treatment as well. And so it’s a radiosensitizer,” he shared. Yet, research into these applications has been neglected. “Big Pharma has completely abandoned it. Ivermectin is off-patent. No one’s going to make money on it,” Dr. Makis pointed out. Taking action where others haven’t, Dr. Makis applied his findings to his practice. “I have over 1,000 cancer patients who are on either a combination of Ivermectin and Fenbendazole or Ivermectin and Mebendazole,” he shared. Some of his patients were “given a terminal diagnosis” but are now “cancer-free” or have their “cancer under control.” “Patients, for example, who are taking combinations of chemo and Ivermectin or radiation and Ivermectin are seeing dramatic results that oncologists have never seen, that radiation oncologists have never seen,” Dr. Makis shared. “Tumors shrinking down to almost nothing, liver metastases disappearing, brain metastases disappearing.” “There are hundreds, if not thousands, of testimonials” documenting the success stories of Ivermectin and Fenbendazole, Dr. Makis added, offering hope to patients seeking alternatives. He strongly believes that “the future of cancer care is in repurposed drugs.” For more information on the use of Ivermectin and Fenbendazole for cancer, follow Dr. William Makis (MakisMD) on 𝕏. --> MakisMD (See 9 More Revealing Stories Below)
22:06

Ivermectin & Fenbendazole Cancer Secrets Revealed w/ Dr. William Makis Remarkable success stories are pouring in from people using Ivermectin and Fenbendazole to combat cancer. Mel Gibson dropped a bombshell on Joe Rogan’s podcast, revealing that three of his friends had “stage four cancer,” and now “all three of them don’t have cancer right now at all.” “And they had some serious stuff going on,” Gibson emphasized. Dr. William Makis, who treated one of Gibson’s friends, has been rigorously researching the anti-cancer potential of Ivermectin and Fenbendazole over the past two years. During that time, he discovered, “There are over 100 papers on the success of Ivermectin and cancer.” “Ivermectin can actually kill cancer stem cells,” Dr. Makis explained, noting that it targets the cells “that chemo can’t kill.” He added, “It can also reverse resistance that cancer cells develop to certain types of chemotherapy.” The benefits extend further. “It [Ivermectin] makes cancer cells susceptible to radiation treatment as well. And so it’s a radiosensitizer,” he shared. Yet, research into these applications has been neglected. “Big Pharma has completely abandoned it. Ivermectin is off-patent. No one’s going to make money on it,” Dr. Makis pointed out. Taking action where others haven’t, Dr. Makis applied his findings to his practice. “I have over 1,000 cancer patients who are on either a combination of Ivermectin and Fenbendazole or Ivermectin and Mebendazole,” he shared. Some of his patients were “given a terminal diagnosis” but are now “cancer-free” or have their “cancer under control.” “Patients, for example, who are taking combinations of chemo and Ivermectin or radiation and Ivermectin are seeing dramatic results that oncologists have never seen, that radiation oncologists have never seen,” Dr. Makis shared. “Tumors shrinking down to almost nothing, liver metastases disappearing, brain metastases disappearing.” “There are hundreds, if not thousands, of testimonials” documenting the success stories of Ivermectin and Fenbendazole, Dr. Makis added, offering hope to patients seeking alternatives. He strongly believes that “the future of cancer care is in repurposed drugs.” For more information on the use of Ivermectin and Fenbendazole for cancer, follow Dr. William Makis (MakisMD) on 𝕏. --> MakisMD (See 9 More Revealing Stories Below)

The Vigilant Fox 🦊

1,292,906 просмотров • 1 год назад

🚨 Prostate Cancer Disappears After Taking Fenbendazole In 2019, a man was diagnosed with prostate cancer and scheduled for surgery. Due to COVID, his surgery was delayed until the summer of 2020. In February, he started taking Fenbendazole (commonly known as a dog dewormer). By the time his surgery date arrived, doctors could no longer find any cancer. His PSA levels had dropped from 11 to between 3 and 4. He canceled the surgery. It’s now been over five years since his diagnosis, and the cancer has not returned. He stopped taking Fenbendazole in 2022. He later wrote a book about his journey called “Finding Fenbendazole” by Roger Rasmussen, which includes science-backed information for those facing cancer. Interestingly, his brother was also diagnosed with prostate cancer in 2022. After following a Fenbendazole and Ivermectin protocol, his PSA levels returned to normal, and doctors could no longer detect the cancer. Stories like this continue to fuel interest in repurposed drugs like Fenbendazole and Ivermectin in cancer care. Access high-quality Ivermectin and Fenbendazole from Dr. David , Worldwide delivery with 24/7 Live human support.
1:30

🚨 Prostate Cancer Disappears After Taking Fenbendazole In 2019, a man was diagnosed with prostate cancer and scheduled for surgery. Due to COVID, his surgery was delayed until the summer of 2020. In February, he started taking Fenbendazole (commonly known as a dog dewormer). By the time his surgery date arrived, doctors could no longer find any cancer. His PSA levels had dropped from 11 to between 3 and 4. He canceled the surgery. It’s now been over five years since his diagnosis, and the cancer has not returned. He stopped taking Fenbendazole in 2022. He later wrote a book about his journey called “Finding Fenbendazole” by Roger Rasmussen, which includes science-backed information for those facing cancer. Interestingly, his brother was also diagnosed with prostate cancer in 2022. After following a Fenbendazole and Ivermectin protocol, his PSA levels returned to normal, and doctors could no longer detect the cancer. Stories like this continue to fuel interest in repurposed drugs like Fenbendazole and Ivermectin in cancer care. Access high-quality Ivermectin and Fenbendazole from Dr. David , Worldwide delivery with 24/7 Live human support.

Dr. David

18,952 просмотров • 20 часов назад

Oncologist Dr. William Makis: "Johns Hopkins quietly secured a patent in 2021 on mebendazole for treatment in cancer...[and is] running, quietly, several clinical trials with mebendazole in cancer...So this is not fringe... There's... real science behind it, patents behind it." "For the past year and a half, I've been working with antiparasitics that are being repurposed for cancer. This is ivermectin, mebendazole and fenbendazole. And the reason is because there's a big body of research. There are over 400 published papers on ivermectin in cancer. There are over 240 published papers on mebendazole in cancer. "In fact, Johns Hopkins quietly secured a patent in 2021 on mebendazole for treatment in cancer, specifically the most aggressive cancer, which is glioblastoma, brain cancer, extremely aggressive cancer. Johns Hopkins has the patent. They are also running quietly several clinical trials with mebendazole in cancer. There's colon cancer, gastric cancer and brain cancer, including children, children with brain cancers as well. So this is not fringe, this is not, something that is far out. There's actually real science behind it, patents behind it. Dr. Sulack Pete "And when you search a lot of the AIs, for example Perplexity AI and you ask what are the most promising repurposed drugs for terminally ill cancer patients today, it will give you in its search, in the top three, you will get ivermectin as number one, mebendazole and fenbendazole, there's other antiparasitics like hydroxychloroquine will be in the top 10, you will have curcumin in the top 10, you will have EGCG, which is from green tea extract in the top 10, resveratrol in the top 10, metformin, which is a diabetes drug but also has anti-cancer activity in the top 10 as well. "And what I have found working with these antiparasitics, is that there is a benefit to patients in at least 75% of the cases." Follow me for more Bombshell. #Fenbendazole #Ivermectin #Cancercure
3:49

Oncologist Dr. William Makis: "Johns Hopkins quietly secured a patent in 2021 on mebendazole for treatment in cancer...[and is] running, quietly, several clinical trials with mebendazole in cancer...So this is not fringe... There's... real science behind it, patents behind it." "For the past year and a half, I've been working with antiparasitics that are being repurposed for cancer. This is ivermectin, mebendazole and fenbendazole. And the reason is because there's a big body of research. There are over 400 published papers on ivermectin in cancer. There are over 240 published papers on mebendazole in cancer. "In fact, Johns Hopkins quietly secured a patent in 2021 on mebendazole for treatment in cancer, specifically the most aggressive cancer, which is glioblastoma, brain cancer, extremely aggressive cancer. Johns Hopkins has the patent. They are also running quietly several clinical trials with mebendazole in cancer. There's colon cancer, gastric cancer and brain cancer, including children, children with brain cancers as well. So this is not fringe, this is not, something that is far out. There's actually real science behind it, patents behind it. Dr. Sulack Pete "And when you search a lot of the AIs, for example Perplexity AI and you ask what are the most promising repurposed drugs for terminally ill cancer patients today, it will give you in its search, in the top three, you will get ivermectin as number one, mebendazole and fenbendazole, there's other antiparasitics like hydroxychloroquine will be in the top 10, you will have curcumin in the top 10, you will have EGCG, which is from green tea extract in the top 10, resveratrol in the top 10, metformin, which is a diabetes drug but also has anti-cancer activity in the top 10 as well. "And what I have found working with these antiparasitics, is that there is a benefit to patients in at least 75% of the cases." Follow me for more Bombshell. #Fenbendazole #Ivermectin #Cancercure

Joe Tippens

46,807 просмотров • 1 месяц назад

🚨Stage 4 Breast Cancer: No Trace of Disease After 8 Months An 83-year-old woman was diagnosed with terminal Stage 4 breast cancer that had spread to her liver, spine, and bones. Doctors described it as a “Death sentence.” She began taking 222 mg of Fenbendazole daily. After 8 months, her liver enzymes returned to normal, and her tumor markers dropped significantly, from 316 to 36. A follow-up PET scan showed no abnormal metabolic activity, indicating no detectable signs of active cancer. While every case is different and more research is still needed, stories like this continue to generate interest in repurposed medications such as Fenbendazole as part of supportive cancer care. If you or a loved one is exploring Fenbendazole or Ivermectin protocols, many people are choosing GENIX MEDS for clean, pharmaceutical-grade products with worldwide delivery.
4:54

🚨Stage 4 Breast Cancer: No Trace of Disease After 8 Months An 83-year-old woman was diagnosed with terminal Stage 4 breast cancer that had spread to her liver, spine, and bones. Doctors described it as a “Death sentence.” She began taking 222 mg of Fenbendazole daily. After 8 months, her liver enzymes returned to normal, and her tumor markers dropped significantly, from 316 to 36. A follow-up PET scan showed no abnormal metabolic activity, indicating no detectable signs of active cancer. While every case is different and more research is still needed, stories like this continue to generate interest in repurposed medications such as Fenbendazole as part of supportive cancer care. If you or a loved one is exploring Fenbendazole or Ivermectin protocols, many people are choosing GENIX MEDS for clean, pharmaceutical-grade products with worldwide delivery.

GENIX MEDS

29,280 просмотров • 1 месяц назад

A New Dawn in the Cancer War: Pioneering "BioShield" Technology Achieves Long-Term Remission Where Others Failed A stunning revelation from Dr. Patrick Soon-Shiong on the dawn of a new medical era. He details a breakthrough he calls "BioShield," a technology designed to prevent cancer by fundamentally educating the body's own immune system. Forget conventional vaccines. This isn't about antibodies. This is about creating a living, intelligent defense system within you. Here’s the concept: "BioShield" educates your T-cells to become elite "memory" cells. They then hide in your bone marrow, lying in wait. When a cancerous cell appears, they emerge to seek and destroy it—stopping cancer before it can ever gain a foothold. This isn't science fiction. It's peer-reviewed, published science with the National Cancer Institute (NCI). And the results are nothing short of remarkable: ➡️ Bladder Cancer: Patients who failed all other treatments and faced radical bladder removal have achieved complete remission for nine years after a simple injection. No surgery. Just a functional cure. ➡️ Pancreatic Cancer: A disease with a grim prognosis, now seeing patients disease-free for five years. The late Senator Harry Reid, after being told by others not to pursue it, saw his tumor markers normalize and lived two active, cancer-free years. ➡️ Merkel Cell Carcinoma & Head/Neck Cancer: Stories of complete responses in patients given weeks to live, with one living nine years and another saved from hospice when his ulcerating tumor melted away. Dr. Soon-Shiong is reframing the conversation. This isn't a "vaccine" in the traditional sense. It's Project BioShield—a proactive, cellular guardian for the body. The takeaway? We are transitioning from toxic, reactive cancer therapies to intelligent, preemptive protection. The age of the immune system as our most powerful shield against cancer has arrived. What are your thoughts on this "BioShield" approach to cancer?
5:12

A New Dawn in the Cancer War: Pioneering "BioShield" Technology Achieves Long-Term Remission Where Others Failed A stunning revelation from Dr. Patrick Soon-Shiong on the dawn of a new medical era. He details a breakthrough he calls "BioShield," a technology designed to prevent cancer by fundamentally educating the body's own immune system. Forget conventional vaccines. This isn't about antibodies. This is about creating a living, intelligent defense system within you. Here’s the concept: "BioShield" educates your T-cells to become elite "memory" cells. They then hide in your bone marrow, lying in wait. When a cancerous cell appears, they emerge to seek and destroy it—stopping cancer before it can ever gain a foothold. This isn't science fiction. It's peer-reviewed, published science with the National Cancer Institute (NCI). And the results are nothing short of remarkable: ➡️ Bladder Cancer: Patients who failed all other treatments and faced radical bladder removal have achieved complete remission for nine years after a simple injection. No surgery. Just a functional cure. ➡️ Pancreatic Cancer: A disease with a grim prognosis, now seeing patients disease-free for five years. The late Senator Harry Reid, after being told by others not to pursue it, saw his tumor markers normalize and lived two active, cancer-free years. ➡️ Merkel Cell Carcinoma & Head/Neck Cancer: Stories of complete responses in patients given weeks to live, with one living nine years and another saved from hospice when his ulcerating tumor melted away. Dr. Soon-Shiong is reframing the conversation. This isn't a "vaccine" in the traditional sense. It's Project BioShield—a proactive, cellular guardian for the body. The takeaway? We are transitioning from toxic, reactive cancer therapies to intelligent, preemptive protection. The age of the immune system as our most powerful shield against cancer has arrived. What are your thoughts on this "BioShield" approach to cancer?

Camus

31,209 просмотров • 9 месяцев назад

Oncologist Dr. William Makis: "Johns Hopkins quietly secured a patent in 2021 on mebendazole for treatment in cancer...[and is] running, quietly, several clinical trials with mebendazole in cancer...So this is not fringe... There's... real science behind it, patents behind it." This clip of Dr. Makis (William Makis), a radiologist, oncologist, and cancer researcher, is taken from an interview with Seth Holehouse () posted to Rumble on November 21, 2025. ----------------Partial transcription of clip--------------- "For the past year and a half, I've been working with antiparasitics that are being repurposed for cancer. This is ivermectin, mebendazole and fenbendazole. And the reason is because there's a big body of research. There are over 400 published papers on ivermectin in cancer. There are over 240 published papers on mebendazole in cancer. "In fact, Johns Hopkins quietly secured a patent in 2021 on mebendazole for treatment in cancer, specifically the most aggressive cancer, which is glioblastoma, brain cancer, extremely aggressive cancer. Johns Hopkins has the patent. They are also running quietly several clinical trials with mebendazole in cancer. There's colon cancer, gastric cancer and brain cancer, including children, children with brain cancers as well. So this is not fringe, this is not, something that is far out. There's actually real science behind it, patents behind it. "And when you search a lot of the AIs, for example Perplexity AI and you ask what are the most promising repurposed drugs for terminally ill cancer patients today, it will give you in its search, in the top three, you will get ivermectin as number one, mebendazole and fenbendazole, there's other antiparasitics like hydroxychloroquine will be in the top 10, you will have curcumin in the top 10, you will have EGCG, which is from green tea extract in the top 10, resveratrol in the top 10, metformin, which is a diabetes drug but also has anti-cancer activity in the top 10 as well. "And what I have found working with these antiparasitics, is that there is a benefit to patients in at least 75% of the cases."
1:59

Oncologist Dr. William Makis: "Johns Hopkins quietly secured a patent in 2021 on mebendazole for treatment in cancer...[and is] running, quietly, several clinical trials with mebendazole in cancer...So this is not fringe... There's... real science behind it, patents behind it." This clip of Dr. Makis (William Makis), a radiologist, oncologist, and cancer researcher, is taken from an interview with Seth Holehouse () posted to Rumble on November 21, 2025. ----------------Partial transcription of clip--------------- "For the past year and a half, I've been working with antiparasitics that are being repurposed for cancer. This is ivermectin, mebendazole and fenbendazole. And the reason is because there's a big body of research. There are over 400 published papers on ivermectin in cancer. There are over 240 published papers on mebendazole in cancer. "In fact, Johns Hopkins quietly secured a patent in 2021 on mebendazole for treatment in cancer, specifically the most aggressive cancer, which is glioblastoma, brain cancer, extremely aggressive cancer. Johns Hopkins has the patent. They are also running quietly several clinical trials with mebendazole in cancer. There's colon cancer, gastric cancer and brain cancer, including children, children with brain cancers as well. So this is not fringe, this is not, something that is far out. There's actually real science behind it, patents behind it. "And when you search a lot of the AIs, for example Perplexity AI and you ask what are the most promising repurposed drugs for terminally ill cancer patients today, it will give you in its search, in the top three, you will get ivermectin as number one, mebendazole and fenbendazole, there's other antiparasitics like hydroxychloroquine will be in the top 10, you will have curcumin in the top 10, you will have EGCG, which is from green tea extract in the top 10, resveratrol in the top 10, metformin, which is a diabetes drug but also has anti-cancer activity in the top 10 as well. "And what I have found working with these antiparasitics, is that there is a benefit to patients in at least 75% of the cases."

Sense Receptor

228,469 просмотров • 9 месяцев назад

🚨 SHE WAS SENT TO HOSPICE WITH CANCER EVERYWHERE… THEN HER PET SCAN WENT COMPLETELY NORMAL. An 83 year old woman had already beaten breast cancer once after her original diagnosis in 2009. But by late 2021, the disease had returned in its most aggressive form. Doctors confirmed metastatic breast cancer in the liver through biopsy. Fluid buildup in the abdomen also tested positive for malignant cancer cells. MRI scans showed tumors throughout the spine including T10, T12, L1 through L5, the sacrum, and pelvic bones. PET scans later revealed multiple hypermetabolic lesions in the lungs and destructive bone tumors spreading into the spinal canal. At this stage, most people understand what this means. This is usually considered terminal disease. The patient reportedly declined further chemotherapy and extensive radiation treatment and was instead placed into hospice care. In other words, end of life management. Then something unexpected happened. In November 2021, she reportedly began self-administering 222mg of Fenbendazole daily while also receiving limited supportive treatment for pain management and hormonal suppression. The radiation she later received only targeted two spinal lesions to help relieve unbearable nerve pain, but it would not have affected the cancer already spread throughout the lungs, liver, pelvis, and the rest of the spine. Yet over the next several months, her condition reportedly changed dramatically. Liver enzymes that had become abnormal returned to normal ranges. Her CA 27.29 tumor marker reportedly dropped from 316 down to 36.6, suggesting a massive reduction in total tumor burden throughout the body. Then came the scan that shocked many people following the case. An April 2022 PET scan reportedly showed NO abnormal metabolic activity associated with active cancer. No activity in the lungs. No activity in the liver. No activity throughout the spine and pelvis where widespread metastatic disease had previously been documented. A patient once placed into hospice care reportedly showed complete metabolic resolution on imaging after months of Fenbendazole use. 👇 Stories like this are exactly why thousands of people are now researching repurposed protocols involving Fenbendazole, Ivermectin, and Mebendazole through GENIX MEDS and following the growing body of research around these compounds. Interest in repurposed antiparasitic drugs continues increasing globally, especially after multiple institutions began publishing research on compounds like Mebendazole in glioblastoma, colon cancer, breast cancer, and pancreatic cancer models. Johns Hopkins researchers have also patented formulations involving Mebendazole for cancer related applications. ⚠️ This post is for informational and educational purposes only. It is not medical advice and does not claim any medication cures cancer. Always consult a qualified healthcare professional before making medical decisions. #Fenbendazole #Ivermectin #Mebendazole #Cancer
4:55

🚨 SHE WAS SENT TO HOSPICE WITH CANCER EVERYWHERE… THEN HER PET SCAN WENT COMPLETELY NORMAL. An 83 year old woman had already beaten breast cancer once after her original diagnosis in 2009. But by late 2021, the disease had returned in its most aggressive form. Doctors confirmed metastatic breast cancer in the liver through biopsy. Fluid buildup in the abdomen also tested positive for malignant cancer cells. MRI scans showed tumors throughout the spine including T10, T12, L1 through L5, the sacrum, and pelvic bones. PET scans later revealed multiple hypermetabolic lesions in the lungs and destructive bone tumors spreading into the spinal canal. At this stage, most people understand what this means. This is usually considered terminal disease. The patient reportedly declined further chemotherapy and extensive radiation treatment and was instead placed into hospice care. In other words, end of life management. Then something unexpected happened. In November 2021, she reportedly began self-administering 222mg of Fenbendazole daily while also receiving limited supportive treatment for pain management and hormonal suppression. The radiation she later received only targeted two spinal lesions to help relieve unbearable nerve pain, but it would not have affected the cancer already spread throughout the lungs, liver, pelvis, and the rest of the spine. Yet over the next several months, her condition reportedly changed dramatically. Liver enzymes that had become abnormal returned to normal ranges. Her CA 27.29 tumor marker reportedly dropped from 316 down to 36.6, suggesting a massive reduction in total tumor burden throughout the body. Then came the scan that shocked many people following the case. An April 2022 PET scan reportedly showed NO abnormal metabolic activity associated with active cancer. No activity in the lungs. No activity in the liver. No activity throughout the spine and pelvis where widespread metastatic disease had previously been documented. A patient once placed into hospice care reportedly showed complete metabolic resolution on imaging after months of Fenbendazole use. 👇 Stories like this are exactly why thousands of people are now researching repurposed protocols involving Fenbendazole, Ivermectin, and Mebendazole through GENIX MEDS and following the growing body of research around these compounds. Interest in repurposed antiparasitic drugs continues increasing globally, especially after multiple institutions began publishing research on compounds like Mebendazole in glioblastoma, colon cancer, breast cancer, and pancreatic cancer models. Johns Hopkins researchers have also patented formulations involving Mebendazole for cancer related applications. ⚠️ This post is for informational and educational purposes only. It is not medical advice and does not claim any medication cures cancer. Always consult a qualified healthcare professional before making medical decisions. #Fenbendazole #Ivermectin #Mebendazole #Cancer

GENIX MEDS

57,707 просмотров • 3 месяцев назад

The Remarkable Cancer-Fighting Benefits of Ivermectin • “Ivermectin can actually kill cancer stem cells,” which are often resistant to chemotherapy. • “It can also reverse resistance that cancer cells develop to chemotherapy,” making treatments more effective. • “It makes cancer cells susceptible to radiation treatment as well. And so it’s a radiosensitizer.” • Patients are seeing “tumors shrinking down to almost nothing, liver metastases disappearing, [and] brain metastases disappearing.” “There are over 100 papers on the success of ivermectin and cancer,” but much of this research has been ignored because the drug is off-patent, meaning “no one’s going to make money on it.” Dr. Makis has treated over 1,000 patients using combinations of ivermectin, fenbendazole, and other therapies. Many of his patients, told by their doctors that there was “nothing they can do for them,” are now “cancer-free” or have their “cancer under control.” The success stories are undeniable, and the hope is spreading. MakisMD
4:13

The Remarkable Cancer-Fighting Benefits of Ivermectin • “Ivermectin can actually kill cancer stem cells,” which are often resistant to chemotherapy. • “It can also reverse resistance that cancer cells develop to chemotherapy,” making treatments more effective. • “It makes cancer cells susceptible to radiation treatment as well. And so it’s a radiosensitizer.” • Patients are seeing “tumors shrinking down to almost nothing, liver metastases disappearing, [and] brain metastases disappearing.” “There are over 100 papers on the success of ivermectin and cancer,” but much of this research has been ignored because the drug is off-patent, meaning “no one’s going to make money on it.” Dr. Makis has treated over 1,000 patients using combinations of ivermectin, fenbendazole, and other therapies. Many of his patients, told by their doctors that there was “nothing they can do for them,” are now “cancer-free” or have their “cancer under control.” The success stories are undeniable, and the hope is spreading. MakisMD

skymeds store | Online Ivermectin Pharmacy

5,142,525 просмотров • 1 год назад

In an interview, Dr. Kathleen Ruddy, a distinguished breast cancer surgeon, author, and inventor, shared groundbreaking insights on repurposed drugs for cancer treatment. She discussed how medications like ivermectin, mebendazole, sildenafil, metformin, aspirin, doxycycline, and vitamin C show promise in targeting cancer stem cells, the drivers of tumor regrowth. “Cancer stem cells are the real bad boys,” Dr. Ruddy stated, explaining that chemotherapy and radiation often fail to eliminate them, leading to cancer recurrence. Preclinical studies show combinations like doxycycline and vitamin C can eradicate over 90% of cancer stem cells, with doxycycline, azithromycin, and vitamin C proving equally effective. These affordable, FDA-approved drugs could halt tumors without harming patients. Dr. Ruddy praised Dr. Paul Marik’s Cancer Care monograph as a must-read for its analysis of repurposed drugs. Her mission is to cure cancer, not manage it as a chronic disease. “Patients want to live without cancer,” she emphasized. Through her work, she’s studying these therapies’ impact on cancers like breast, prostate, and lung. “Kill the cancer, or the cancer will kill you,” Dr. Ruddy urged. Could repurposed drugs transform cancer care?
3:41

In an interview, Dr. Kathleen Ruddy, a distinguished breast cancer surgeon, author, and inventor, shared groundbreaking insights on repurposed drugs for cancer treatment. She discussed how medications like ivermectin, mebendazole, sildenafil, metformin, aspirin, doxycycline, and vitamin C show promise in targeting cancer stem cells, the drivers of tumor regrowth. “Cancer stem cells are the real bad boys,” Dr. Ruddy stated, explaining that chemotherapy and radiation often fail to eliminate them, leading to cancer recurrence. Preclinical studies show combinations like doxycycline and vitamin C can eradicate over 90% of cancer stem cells, with doxycycline, azithromycin, and vitamin C proving equally effective. These affordable, FDA-approved drugs could halt tumors without harming patients. Dr. Ruddy praised Dr. Paul Marik’s Cancer Care monograph as a must-read for its analysis of repurposed drugs. Her mission is to cure cancer, not manage it as a chronic disease. “Patients want to live without cancer,” she emphasized. Through her work, she’s studying these therapies’ impact on cancers like breast, prostate, and lung. “Kill the cancer, or the cancer will kill you,” Dr. Ruddy urged. Could repurposed drugs transform cancer care?

Camus

117,774 просмотров • 1 год назад

Ivermectin, Mebendazole, Fenbendazole BREAKING NEWS: First-in-the-World Ivermectin, Mebendazole, and Fenbendazole Protocol in Cancer Has Been Peer-Reviewed and Published on Sep. 19, 2024! Cancer researcher: IVERMECTIN can overcome chemotherapy resistance of TURBO CANCERS caused by mRNA vaccines: IVERMECTIN should be given to ALL Advanced Breast Cancer patients – outperforms chemo Paclitaxel & kills Cancer Stem Cells! 🌸🌼🌸🌼🌸🌼🌸🌼🌸🌼🌸🌼🌸🌼🌸 🚨BREAST CANCER = PARASITES🚨MAMOGRAPHY IS THE BIGGEST ORGANIZED CRIME AGAINST WOMEN!! Women who go for mammograms are probably unaware of the harm they do to themselves 😩 A few details to consider before deciding on a review: ✅ 50-60% of the “positive” results are incorrect!! So, being diagnosed with “breast cancer” in 50-60% of cases, turns out it didn’t exist at all!! ✅ during examination, the breast is pressed with a large weight of 10kPa (1019 kg / m2) and then healthy, very sensitive, milk gland tissue is bombarded by radioactive rays!! ✅ stimulates tumor growth and the spread of metastases!! ✅ study done on 690,000 records showed that completely healthy women have developed breast cancer in a large number of cases after mammographic examinations!! MakisMD Elon Musk Donald J. Trump #Ivermectin #CancerAwareness
8:54

Ivermectin, Mebendazole, Fenbendazole BREAKING NEWS: First-in-the-World Ivermectin, Mebendazole, and Fenbendazole Protocol in Cancer Has Been Peer-Reviewed and Published on Sep. 19, 2024! Cancer researcher: IVERMECTIN can overcome chemotherapy resistance of TURBO CANCERS caused by mRNA vaccines: IVERMECTIN should be given to ALL Advanced Breast Cancer patients – outperforms chemo Paclitaxel & kills Cancer Stem Cells! 🌸🌼🌸🌼🌸🌼🌸🌼🌸🌼🌸🌼🌸🌼🌸 🚨BREAST CANCER = PARASITES🚨MAMOGRAPHY IS THE BIGGEST ORGANIZED CRIME AGAINST WOMEN!! Women who go for mammograms are probably unaware of the harm they do to themselves 😩 A few details to consider before deciding on a review: ✅ 50-60% of the “positive” results are incorrect!! So, being diagnosed with “breast cancer” in 50-60% of cases, turns out it didn’t exist at all!! ✅ during examination, the breast is pressed with a large weight of 10kPa (1019 kg / m2) and then healthy, very sensitive, milk gland tissue is bombarded by radioactive rays!! ✅ stimulates tumor growth and the spread of metastases!! ✅ study done on 690,000 records showed that completely healthy women have developed breast cancer in a large number of cases after mammographic examinations!! MakisMD Elon Musk Donald J. Trump #Ivermectin #CancerAwareness

skymeds store | Online Ivermectin Pharmacy

3,350,823 просмотров • 1 год назад

BREAKING NEWS: First-in-the-World Ivermectin, Mebendazole and Fenbendazole Protocol in Cancer has been peer-reviewed and published! (4 min 52 seconds) InfoWars did a media piece on this breakthrough in Cancer Treatment. These are Critical medicines to have on hand. They ship from outside the USSA by our Freedom Crew. They cannot be stopped by lunatic big pharma control freaks. FREEDOM MEDICINE for the WIN "You can use high dose Ivermectin for the majority of Cancers...this is a dose that is 5 to 10 times the dose that people were using for COVID-19". Big Pharma stands to make No Big Money in treating aggressive cancers with High Dose Ivermectin, Fenbendazole, and Turmeric (curcumin). For example, Fenbendazole upregulates p53 tumor suppressor levels, that are low in people who took COVID-19 injections and developed Turbo Cancer. Please Share! Follow for more Bombshell.
4:52

BREAKING NEWS: First-in-the-World Ivermectin, Mebendazole and Fenbendazole Protocol in Cancer has been peer-reviewed and published! (4 min 52 seconds) InfoWars did a media piece on this breakthrough in Cancer Treatment. These are Critical medicines to have on hand. They ship from outside the USSA by our Freedom Crew. They cannot be stopped by lunatic big pharma control freaks. FREEDOM MEDICINE for the WIN "You can use high dose Ivermectin for the majority of Cancers...this is a dose that is 5 to 10 times the dose that people were using for COVID-19". Big Pharma stands to make No Big Money in treating aggressive cancers with High Dose Ivermectin, Fenbendazole, and Turmeric (curcumin). For example, Fenbendazole upregulates p53 tumor suppressor levels, that are low in people who took COVID-19 injections and developed Turbo Cancer. Please Share! Follow for more Bombshell.

Joe Tippens

45,472 просмотров • 16 дней назад

🚨 STAGE 4 BREAST CANCER. HOSPICE CARE. EIGHT MONTHS LATER, THE PET SCAN SHOCKED EVERYONE. A 33-year-old woman was facing a devastating diagnosis. Her breast cancer had returned. And this time it had spread. 📌 Liver 📌 Lungs 📌 Spine 📌 Pelvis 📌 Multiple vertebrae 📌 Bones A liver biopsy confirmed metastatic breast cancer. MRI scans showed cancer throughout her spine and skeletal system. PET scans revealed multiple hypermetabolic lung and bone lesions. The disease was widespread. By late 2021, she declined further conventional chemotherapy and was placed under hospice care. For many patients, that's where the story ends. But in November 2021, she began taking 222mg of Fenbendazole daily. At the start: • Cancer was confirmed in her liver • Cancer was confirmed in her bones • Multiple lung lesions were present • Tumor marker CA27.29 measured 316 Over the next several months, she continued taking 222mg of Fenbendazole daily. Then something remarkable happened. ✅ Liver enzymes returned to normal ✅ Tumor marker CA27.29 dropped from 316 to 36.6 ✅ Pain from spinal metastases improved And then came the PET scan. In April 2022, follow-up imaging reportedly showed no abnormal metabolic activity indicative of cancer. Think about that. The previous scans had shown active disease in the liver, lungs, spine, pelvis, and bones. Months later, the PET scan reportedly found no evidence of abnormal cancer activity. Cases like this are why Fenbendazole continues to attract attention around the world. Not because of opinions. Because people are looking at scans. Looking at lab results. Looking at outcomes. And deciding for themselves what questions deserve answers. 💊 Looking for Fenbendazole, Ivermectin, or Mebendazole? Explore RXMEDS.STORE. #Fenbendazole #BreastCancer #CancerResearch #RepurposedDrugs #Oncology #RxMeds
4:54

🚨 STAGE 4 BREAST CANCER. HOSPICE CARE. EIGHT MONTHS LATER, THE PET SCAN SHOCKED EVERYONE. A 33-year-old woman was facing a devastating diagnosis. Her breast cancer had returned. And this time it had spread. 📌 Liver 📌 Lungs 📌 Spine 📌 Pelvis 📌 Multiple vertebrae 📌 Bones A liver biopsy confirmed metastatic breast cancer. MRI scans showed cancer throughout her spine and skeletal system. PET scans revealed multiple hypermetabolic lung and bone lesions. The disease was widespread. By late 2021, she declined further conventional chemotherapy and was placed under hospice care. For many patients, that's where the story ends. But in November 2021, she began taking 222mg of Fenbendazole daily. At the start: • Cancer was confirmed in her liver • Cancer was confirmed in her bones • Multiple lung lesions were present • Tumor marker CA27.29 measured 316 Over the next several months, she continued taking 222mg of Fenbendazole daily. Then something remarkable happened. ✅ Liver enzymes returned to normal ✅ Tumor marker CA27.29 dropped from 316 to 36.6 ✅ Pain from spinal metastases improved And then came the PET scan. In April 2022, follow-up imaging reportedly showed no abnormal metabolic activity indicative of cancer. Think about that. The previous scans had shown active disease in the liver, lungs, spine, pelvis, and bones. Months later, the PET scan reportedly found no evidence of abnormal cancer activity. Cases like this are why Fenbendazole continues to attract attention around the world. Not because of opinions. Because people are looking at scans. Looking at lab results. Looking at outcomes. And deciding for themselves what questions deserve answers. 💊 Looking for Fenbendazole, Ivermectin, or Mebendazole? Explore RXMEDS.STORE. #Fenbendazole #BreastCancer #CancerResearch #RepurposedDrugs #Oncology #RxMeds

RXMEDS.STORE

16,476 просмотров • 2 месяцев назад

Megyn Kelly sat down with Dr. Patrick Soon-Shiong to discuss his revolutionary cancer protocol—a treatment that has already extended lives by years for patients with terminal diagnoses, including the late Senator Harry Reid. The Science Behind the Breakthrough Dr. Soon-Shiong’s approach challenges conventional cancer treatments like chemotherapy and radiation, which destroy the immune system’s natural killer (NK) cells and T-cells—critical for fighting cancer. His BioStripe treatment works by rebuilding the immune system, even in patients who have exhausted all other options. Real Patients, Miraculous Results Merkel cell carcinoma (5th-line treatment): Complete remission—patient lived 6+ years and didn’t die from cancer. Bladder cancer: Patients still alive 10-11 years later. Triple-negative breast cancer: Multiple complete remissions. Metastatic pancreatic cancer: One patient disease-free after 5 years, now 6+ years and counting. FDA Roadblocks & Lost Time Despite undeniable success, Dr. Soon-Shiong faced years of resistance from regulators. In 2015, he proposed testing his method before chemo/radiation—but the FDA insisted on starting with end-stage patients. After 700,000 pages of submissions, approval finally came in late 2024. The Future: Beyond Cancer This treatment isn’t just for cancer—it’s showing promise against sepsis and severe infections. One recent case: A Valley Fever patient on a ventilator, given last rites—fully recovered after treatment. The Urgent Question Why is bureaucracy slowing down a therapy that could save millions? With pancreatic cancer, glioblastoma, and lung cancer patients still dying every day, how many more lives could have been saved if this had been fast-tracked?
3:46

Megyn Kelly sat down with Dr. Patrick Soon-Shiong to discuss his revolutionary cancer protocol—a treatment that has already extended lives by years for patients with terminal diagnoses, including the late Senator Harry Reid. The Science Behind the Breakthrough Dr. Soon-Shiong’s approach challenges conventional cancer treatments like chemotherapy and radiation, which destroy the immune system’s natural killer (NK) cells and T-cells—critical for fighting cancer. His BioStripe treatment works by rebuilding the immune system, even in patients who have exhausted all other options. Real Patients, Miraculous Results Merkel cell carcinoma (5th-line treatment): Complete remission—patient lived 6+ years and didn’t die from cancer. Bladder cancer: Patients still alive 10-11 years later. Triple-negative breast cancer: Multiple complete remissions. Metastatic pancreatic cancer: One patient disease-free after 5 years, now 6+ years and counting. FDA Roadblocks & Lost Time Despite undeniable success, Dr. Soon-Shiong faced years of resistance from regulators. In 2015, he proposed testing his method before chemo/radiation—but the FDA insisted on starting with end-stage patients. After 700,000 pages of submissions, approval finally came in late 2024. The Future: Beyond Cancer This treatment isn’t just for cancer—it’s showing promise against sepsis and severe infections. One recent case: A Valley Fever patient on a ventilator, given last rites—fully recovered after treatment. The Urgent Question Why is bureaucracy slowing down a therapy that could save millions? With pancreatic cancer, glioblastoma, and lung cancer patients still dying every day, how many more lives could have been saved if this had been fast-tracked?

Camus

615,537 просмотров • 1 год назад